| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 23.08.2019 og
angivet som gældende fra 22.08.2019 (1912
dage). |
Ingen historik.
| Branche | | Fremstilling af medicinske og dentale instrumenter samt udstyr hertil (325000). |
| Sidst opdateret den 23.08.2019 og
angivet som gældende fra 22.08.2019 (1912
dage). |
Ingen historik.
| Revisionfravalgt | | false. |
| Sidst opdateret den 25.06.2024 og
angivet som gældende fra 23.06.2024 (145
dage). |
| Historik | Start | Stop |
|---|
| false | 23.06.2024 | |
| true | 22.08.2019 | 22.06.2024 |
| Kontaktoplysninger | | info@medicquant.com. |
| Sidst opdateret den 28.04.2023 og
angivet som gældende fra 25.04.2023 (570
dage). |
| Historik | Start | Stop |
|---|
| info@medicquant.com | 25.04.2023 | |
| ldn@medicquant.com | 23.09.2021 | 24.04.2023 |
| line@debois.dk | 22.08.2019 | 22.09.2021 |
| Telefonnummer | | 31228410. |
| Sidst opdateret den 23.08.2019 og
angivet som gældende fra 22.08.2019 (1912
dage). |
Ingen historik.
| Navne | | MedicQuant ApS. |
| Sidst opdateret den 23.08.2019 og
angivet som gældende fra 22.08.2019 (1912
dage). |
Ingen historik.
| Tegningsregel | | Selskabet tegnes af bestyrelsens formand i forening med en direktør eller af den samlede bestyrelse. |
| Sidst opdateret den 01.07.2024 og
angivet som gældende fra 01.07.2024 (137
dage). |
| Fortolkning
(2 tegningsmuligheder)
| | formanden + 1 direktør |
| bestyrelsen |
| Historik | Start | Stop |
|---|
| Selskabet tegnes af bestyrelsens formand i forening med en direktør eller af den samlede bestyrelse | 01.07.2024 | |
| Selskabet tegnes af bestyrelsens formand i forening med den administrerende direktør eller af den samlede bestyrelse | 11.04.2023 | 30.06.2024 |
| Virksomheden tegnes af direktøren i forening med et bestyrelsesmedlem, eller af den samlede bestyrelse | 24.01.2020 | 10.04.2023 |
| Virksomheden tegnes af Line Debois Frejlev Nielsen, Malthe Hansen-Bruhn og Kurt Vesterager Gothelf | 22.08.2019 | 23.01.2020 |
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:KPMG
Revisionsvirksomhedens CVR-nr.:25578198
Virksomhedens regnskabsklasse:Reporting class B
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):We have audited the financial statements of MedicQuant ApS for the financial year 1 January - 31 December 2023, comprising income statement, balance sheet, statement of changes in equity and notes, including accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2023 and of the results of the Company's operations for the financial year 1 January - 31 December 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on the Management's reviewManagement is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of the Management's review.
| Bibranche | | Fremstilling af farmaceutiske præparater. |
| Sidst opdateret den 23.08.2019
og
angivet som gældende fra 22.08.2019 (1912
dage). |
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration